Skip to main content

Cryo Cell International Inc

CCEL
Exchange
NYSE
Industry
Services-Misc Health & Allied Services, NEC
SEC CIK
0000862692

No open-market purchases or sales by Cryo Cell International Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $1.77M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Cryo Cell International Inc changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of CCEL: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders17111−5
Shares982.9K151.0K532.7K−299.2K (−36.0%)
Value$3.38M$519.4K$1.89M−$970.2K (−33.9%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (2)

Institutions that held Cryo Cell International Inc at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to CCEL in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC161,524$573.4K0.00%
Vanguard Fiduciary Trust Co23,346$82.9K0.00%

Sold out (7)

Institutions that held Cryo Cell International Inc at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of CCEL in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Hamilton Lane Advisors LLC409,734$1.41M
Northern Trust Corp28,716$98.8K
Cerity Partners LLC19,563$67.3K
Citadel Advisors LLC14,525$50.0K
Tower Research Capital LLC (TRC)1,222$4.20K
Bank of America Corp3$10
Royal Bank of Canada105$0

Not filed for Q1 2026 yet (1)

Institutions that held Cryo Cell International Inc at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CCEL in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc150,991$519.4K